Thyroid cancer Flashcards

1
Q

what could ddx be for solitary thyroid nodule

A
cyst 
colloid nodule 
bengin follicular adenoma 
hyperplastic nodule 
papillary/follicular/medullary/anaplastic cancer 
lymphoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how is a minimally invasive and vasular invasive follicular thyroid carcinoma managed

A

minimally invasive - lobectomy

invasion of vasculature or significant invasion then total thyroidectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the tumour cell marker in meduallary cell cancer

A

calcitonin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

causes of medullary cell cancer?

A

sporadic, familial non MEN, or familial MEN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

features of MEN2a?

A

MTC, hyperparathyroidism, phaeochromocytoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

how would you possibly manage MEN2a

A

prophylactic thyroidectomy as a child

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

biggest risk factor for thyroid lymphoma and how may it present

A

AA hypothyroidism

rapid onset mass in thyroid in female 70-80s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how would a lymphoma of the thyroid be managed

A

FNA or biopsy for histology then chemo, DXT, steroids, radiotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the bethesda classification on FNA

A
thy1 inadequate 
thy2 benign 
thy3 atypical 
thy4 probs malignant 
thy5 malignant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how would you recognise a low risk papillary cell carcinoma and what is the management

A

<50 and tumour <4cm
lobectomy
lower TSH and baseline Tg to monitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how would you recognise a high risk papillary cell carcinoma and what is the management

A

anything not in low risk category
total thyroidectomy with consiered radioactive iodine
TSH<1mU/L
annual Tg monitor as tumour cell marker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

follow up for thyroid cancer

A

low risk may be discharged post 5y

get TSH/Tg for 6m for the first 5y and if not discharged then annually

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what features may be seen on multinodular goitre on CT

A

retrosternal extension

tracheal deviation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

when would you offer surgery for multinodular goitre causing issues

A

lifestyle interfering symptoms
stridor
tracheal compression and symptomatic
possibility of cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what does differentiated thyroid cancer refer to?

A

papillary and follicular cancers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

risk factors for DTC

A

females
no association with diet, FHx, malignancy, smoking
ionising radiation exposure is the exception

17
Q

investigation of DTC

A

USS FNA
excision biopsy of lymph node
pre op laryngoscopy if vocal cord palsy

18
Q

why would a subtotal thyroidectomy be done over total

A

risk to damage of recurrent larygeal nerves

19
Q

when would a total body iodine scan be done

A

3-6m post op subtotal or total thyroidectomy

20
Q

describe the use of rhTSH and total body iodine scan

A

engineered to raise TSH<20
monday/tuesday IM injection
on wed give I-131
image on fri

21
Q

what would you see on a total body iodine scan

A

physiological uptake into salivary glands, pituitary and concentration in stomach and bladder
may see thyroid remnant in sub-total thyroidectomy

22
Q

side effects of thyroid remnant ablation

A

sialadenitis

sore throat

23
Q

how is thyroid remnant conducted

A

pre treatment with rhTSH and higher dose I-131
patient admitted to lead lined room, use of disposable cutlery, sheets and clothing are stored until deemed safe with little contact with visitors/nurses

24
Q

what are the TSH/FT4 aims post radioactive remnant ablation

A

TSH<0.1mU/l
FT4<25
use throxine to suppress TSH but not too much to increase FT4

25
Q

describe possibly issues in using Tg as a tumour marker post radioactive remnant ablation

A

need suppressed TSH
anti-Tg Ab may affect result if +ve
presure pre op as not all subjects secrete Tg

26
Q

long term effects of I-131 ablation

A

small, but significant risk in AML in those with repeated high doses within 12m

27
Q

how may recurring differentiated thyroid cancer present

A

lymphadenopathy - papillary
haematogenous mets - follicular
rising Tg or spotted on imaging - usually I-131 but also PET

28
Q

what is the recurrence rate of differentiated thyroid cancer

A

30%

29
Q

management of DTC refractory to I-131 management

A

sorafenib, lenvatinib
tyrosine kinase inhibitors thought to be of benefit
small patient evidence base